Cipla gets USFDA nod for inhalation product
Admin
Jun 28, 2021 12:28
65
Drug major Cipla on Wednesday said it has received final approval from the US health regulator for Arformoterol Tartrate Inhalation Solution, used to treat conditions like chronic bronchitis and emphysema, in the US market.
